Exclusion of Serum- and Glucocorticoid-Induced Kinase 1 (SGK1) as a Candidate Gene for Genetically Heterogeneous Renal Pseudohypoaldosteronism Type I in Eight Families

2007 ◽  
Vol 27 (2) ◽  
pp. 164-169 ◽  
Author(s):  
Felix G. Riepe ◽  
Paul-Martin Holterhus
2004 ◽  
Vol 24 (5) ◽  
pp. 483-487 ◽  
Author(s):  
Catherine L. Huey ◽  
Felix G. Riepe ◽  
Wolfgang G. Sippell ◽  
Alan S.L. Yu

10.1038/966 ◽  
1998 ◽  
Vol 19 (3) ◽  
pp. 279-281 ◽  
Author(s):  
David S. Geller ◽  
Juan Rodriguez-Soriano ◽  
Alfredo V. Boado ◽  
Søren Schifter ◽  
Milan Bayer ◽  
...  

Author(s):  
Markus Braun-Falco ◽  
Henry J. Mankin ◽  
Sharon L. Wenger ◽  
Markus Braun-Falco ◽  
Stephan DiSean Kendall ◽  
...  

1986 ◽  
Vol 113 (4_Suppl) ◽  
pp. S381-S385 ◽  
Author(s):  
E.A. WERDER ◽  
W. HILBE ◽  
M.B. VALLOTTON

Abstract In an infant with pseudohypoaldosteronism type I increased urinary excretion of PGE2 (1.32 ng/mg creatinine; normal mean ± SE: 0.50 ± 0.10) and PGF2α (6.15 ng/mg creatinine; normal mean ± SE: 2.93 ± 0.91) was found. Prostaglandin excretion as well as the typical hyperkalemia, hyperreninemia and hyperaldosteronism normalized with adequate dietary salt supplementation. An abnormally high excretion of the renal prostaglandins was again present at age 4.4 years when the child was thriving although additional salt was withheld. These abnormalities are considered to be secondary to this condition's basic defect which remains to be elucidated.


2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Nasifa Nur ◽  
Cameron Lang ◽  
Juanita K. Hodax ◽  
Jose Bernardo Quintos

Systemic pseudohypoaldosteronism (PHA) type I is a rare genetic disorder resulting from mutations in the subunits of the epithelial sodium channel that manifests as severe salt wasting, hyperkalemia, and metabolic acidosis in infancy. In this article we report a patient with systemic PHA type I presenting with severe dehydration due to salt wasting at 6 days of life. She was found to have a known mutation in the SCNN1A gene and subsequently required treatment with sodium supplementation. We also review the clinical presentation, differential diagnosis, and treatment of systemic PHA type I and summarize data from 27 cases with follow-up data.


2014 ◽  
Vol 2 (6) ◽  
pp. 326-330 ◽  
Author(s):  
Gunjeet Kala Ahluwalia ◽  
Majed Dasouki ◽  
Angela Lennon

2021 ◽  
pp. 1-3
Author(s):  
Deani H. McVadon ◽  
John M. Costello ◽  
Katherine E. Twombley ◽  
Sinai C. Zyblewski

Abstract Pseudohypoaldosteronism type I is caused by a peripheral resistance to aldosterone and can present with electrolyte abnormalities, poor growth, or dehydration. Although a rare disease, several case reports have been published regarding Pseudohypoaldosteronism type I in neonates and infants. We report a case of failure to thrive and hyponatremia in an infant with hypoplastic left heart syndrome who was subsequently found to have Pseudohypoaldosteronism type I.


1999 ◽  
Vol 104 (7) ◽  
pp. 967-974 ◽  
Author(s):  
Olivier Bonny ◽  
Ahmed Chraibi ◽  
Jan Loffing ◽  
Nicole Fowler Jaeger ◽  
Stefan Gründer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document